“Imaging can provide key insight on cardiorenal effects, important for both mode of action as well as drug efficacy and safety in drug development” – Paul Hockings, Senior Imaging Director
Read more about imaging in cardiorenal drug development: https://antarosmedical.com/case-studies/seeing-the-holistic-perspective-cardiorenal